Announced
Completed
Spectralytic Scientific completed the acquisition of AES assets from PerkinElmer.
Financials
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
United States
Biotechnology
Acquisition
Cross Border
Private
gene editing
Completed
Single Bidder
Majority
Friendly
Synopsis
Spectralytic Scientific completed the acquisition of AES assets from PerkinElmer, a diagnostics, life science research, food, environmental and industrial testing provider. Financial terms were not disclosed.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.